PON1 and stroke disorder: Circulating paraoxonase-1, a potential clinically useful biomarker for IS diagnosis [8,9,10,11], has been reported to inhibit the progression of atherosclerosis and lower the risk of stroke by protecting lipoproteins against oxidative modification [12,13,14].